Загрузка...
Recurrent hepatogastric fistula during lenvatinib therapy for advanced hepatocellular carcinoma managed by over-the-scope clip closure: a case report
Objective: Lenvatinib is an oral multitarget tyrosine kinase inhibitor (mTKI) and is recommended for patients with advanced hepatocellular carcinoma (HCC) with Child-Pugh A liver function, who are not amenable to surgical resection, locoregional treatment, or transcatheter arterial chemoembolization...
Сохранить в:
| Опубликовано в: : | J Rural Med |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
The Japanese Association of Rural Medicine
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8016677/ https://ncbi.nlm.nih.gov/pubmed/33833836 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2185/jrm.2020-044 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|